Didier Cowling

Testmate Health is a an early stage healthcare startup focused on low cost, high quality & accurate at home self-testing. Our team brings together expertise in sexual health and diagnostics to bring our mission of making testing for sexual health easy and accessible to life. STI rates have soared in recent years, partly due to a reduction in access to easy & affordable testing. Yet, it is asymptomatic in nearly 80% of women, and causes preventable complications during pregnancy and childbirth. Testmate Health is developing the first OTC urine home test for common STIs, that can be performed anywhere, at anytime, providing results in minutes. Testmate Health raised an over-subscribed Seed Round to accelerate development, and validate their disposable test. Awards and Accelerators: 1. MassChallenge Switzerland 2019 2. HelloTomorrow Top 100 2019 3. Google For Startups Womens Health 2021 4. De Vigier Foundation Award 2021 5. Biopole Startup Award 2022

ARTIRIA empowers catheters and guidewires. We develop cutting edge technologies to bring micromotion deep in the brain arteries, enabling a seamless navigation and stroke treatment. ARTIRIA comprises a passionate team willing to bring a new standard of care to stroke surgeons for the benefit of their patients.

Headquartered in Geneva, Switzerland, Plair SA designs, manufactures and commercializes advanced laser-based instruments for microbial detection. The company was founded in 2014 to revolutionize environmental monitoring.

We are a start-up medical device company originating from ETH Zurich and are passionate about developing life saving therapies. Our mission is to develop a breakthrough medical device for the most urgent healthcare issues. Focusing on patients’ needs, we translate the most promising research to the clinics and ensure patient access to scientific progress as soon as possible. As pioneers we take courageous decisions and are shaping the future of medicine. We first focus on finding an efficient therapy for patients with sepsis, a devastating condition causing millions of deaths annually.

Spine-related pain is taking a huge toll on our society: more bed-days, more days off work, and at a greater financial cost to westernized healthcare than any other condition. We’re on a mission to ease this burden through superior biologics for better spinal fusions. We believe that a greater quality and quantity of science holds the key to easing the burden of back surgery. Every day, we put our 150 years’ combined research experience to work in achieving this, which includes: 10 well-controlled Level I-III clinical trials initiated. >25 orthobiologics-related patents. >400 patients evaluated in Level I, randomized controlled clinical trials. >15,000 patients successfully treated. Today, nearly 1 in 5 spinal fusions fail. But what can we do to change this situation - for the benefit of patients, surgeons and our wider society? This is the question that drives us at Kuros. Every day our team works across three continents to unlock the hidden secrets of bone healing through our research, development & technology program: Project Fusion. To deliver the ideal bone graft, we believe you need the highest quality & quantity of scientific evidence behind it. Which is why Project Fusion brings together an unprecedented blend of scientific, pre-clinical and clinical studies – all aimed at making the unpredictable…predictable. CONTACT KUROS TO FIND OUT MORE >>>>

Spine-related pain is taking a huge toll on our society: more bed-days, more days off work, and at a greater financial cost to westernized healthcare than any other condition. We’re on a mission to ease this burden through superior biologics for better spinal fusions. We believe that a greater quality and quantity of science holds the key to easing the burden of back surgery. Every day, we put our 150 years’ combined research experience to work in achieving this, which includes: 10 well-controlled Level I-III clinical trials initiated. >25 orthobiologics-related patents. >400 patients evaluated in Level I, randomized controlled clinical trials. >15,000 patients successfully treated. Today, nearly 1 in 5 spinal fusions fail. But what can we do to change this situation - for the benefit of patients, surgeons and our wider society? This is the question that drives us at Kuros. Every day our team works across three continents to unlock the hidden secrets of bone healing through our research, development & technology program: Project Fusion. To deliver the ideal bone graft, we believe you need the highest quality & quantity of scientific evidence behind it. Which is why Project Fusion brings together an unprecedented blend of scientific, pre-clinical and clinical studies – all aimed at making the unpredictable…predictable. CONTACT KUROS TO FIND OUT MORE >>>>

Testmate Health is a an early stage healthcare startup focused on low cost, high quality & accurate at home self-testing. Our team brings together expertise in sexual health and diagnostics to bring our mission of making testing for sexual health easy and accessible to life. STI rates have soared in recent years, partly due to a reduction in access to easy & affordable testing. Yet, it is asymptomatic in nearly 80% of women, and causes preventable complications during pregnancy and childbirth. Testmate Health is developing the first OTC urine home test for common STIs, that can be performed anywhere, at anytime, providing results in minutes. Testmate Health raised an over-subscribed Seed Round to accelerate development, and validate their disposable test. Awards and Accelerators: 1. MassChallenge Switzerland 2019 2. HelloTomorrow Top 100 2019 3. Google For Startups Womens Health 2021 4. De Vigier Foundation Award 2021 5. Biopole Startup Award 2022

ARTIRIA empowers catheters and guidewires. We develop cutting edge technologies to bring micromotion deep in the brain arteries, enabling a seamless navigation and stroke treatment. ARTIRIA comprises a passionate team willing to bring a new standard of care to stroke surgeons for the benefit of their patients.

Headquartered in Geneva, Switzerland, Plair SA designs, manufactures and commercializes advanced laser-based instruments for microbial detection. The company was founded in 2014 to revolutionize environmental monitoring.

We are a start-up medical device company originating from ETH Zurich and are passionate about developing life saving therapies. Our mission is to develop a breakthrough medical device for the most urgent healthcare issues. Focusing on patients’ needs, we translate the most promising research to the clinics and ensure patient access to scientific progress as soon as possible. As pioneers we take courageous decisions and are shaping the future of medicine. We first focus on finding an efficient therapy for patients with sepsis, a devastating condition causing millions of deaths annually.